Uganda has received a major boost in its battle against infectious diseases, securing a $521 million grant from the Global Fund under its Grant Cycle 8 (2026–2028).
This funding marks a significant step forward in the country’s ongoing efforts to combat HIV, tuberculosis, and malaria—three of the most pressing public health challenges.
The announcement followed a high-level meeting at the Ministry of Finance headquarters in Kampala, where Permanent Secretary and Secretary to the Treasury, Ramathan Ggoobi, met with Linden Morrison, the Global Fund’s High-Impact Head for Africa.
He was joined by Dr Eliud Wandwalo, who leads tuberculosis programmes at the Global Fund, and Dawson Kalemba of PricewaterhouseCoopers (PwC), the Local Fund Agent.
Discussions centred on strengthening Uganda’s health financing systems and ensuring the effective rollout of the new grant. Government officials emphasised accountability and transparency in managing the funds, reaffirming their commitment to maintaining high standards of financial oversight.
Ggoobi welcomed the continued partnership, highlighting Uganda’s dedication to responsible fund management and its determination to maximise the impact of the grant. In response, Morrison commended Uganda’s strong track record in implementing health programmes and its leadership in regional health initiatives.
However, he also stressed the importance of long-term sustainability. While donor funding remains crucial, Uganda has been encouraged to develop strategies that ensure health programmes can continue delivering results even beyond external support.
The meeting also included Johnson Mutesigensi, Coordinator of the Public Financial Management Reforms Unit, who pointed to ongoing efforts to strengthen financial systems and oversight mechanisms.
The Global Fund partnership continues to play a vital role in Uganda’s public health response, supporting nationwide efforts to reduce disease burden and expand access to essential prevention and treatment services.
